Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Patrick M. McCarthy, G. Travis Clifton, Timothy J. Vreeland, Alexandra M. Adams, Anne E. O’Shea & George E. Peoples. (2021) AE37: a HER2-targeted vaccine for the prevention of breast cancer recurrence. Expert Opinion on Investigational Drugs 30:1, pages 5-11.
Read now
Read now
Articles from other publishers (15)
Wonjun Ji, In-Jae Oh, Cheol-Kyu Park, Sung Yong Lee, Juwhan Choi, Jae Cheol Lee, Jiwon Kim & Seung Hyeun Lee. (2023) Real-World Treatment Outcomes and Safety of Afatinib in Advanced Squamous Cell Lung Cancer Progressed after Platinum-Based Doublet Chemotherapy and Immunotherapy (SPACE Study). Cancers 15:23, pages 5568.
Crossref
Crossref
Priyanka Sahu, Chantal Donovan, Keshav Raj Paudel, Sophie Pickles, Vrushali Chimankar, Richard Y. Kim, Jay C. Horvart, Kamal Dua, Antonio Ieni, Francesco Nucera, Helle Bielefeldt-Ohmann, Sarah Mazilli, Gaetano Caramori, J. Guy Lyons & Philip M. Hansbro. (2023) Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions. Frontiers in Oncology 13.
Crossref
Crossref
Chengpeng Zhang, Yong Huang, Chen Fang, Yingkuan Liang, Dong Jiang, Jiaxi Li, Haitao Ma, Wei Jiang & Yu Feng. (2023) Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma. Cancer Biomarkers 36:4, pages 313-326.
Crossref
Crossref
Yuanwang Pan, Han Han, Hai Hu, Hua Wang, Yueqiang Song, Yuan Hao, Xinyuan Tong, Ayushi S. Patel, Selim Misirlioglu, Sittinon Tang, Hsin-Yi Huang, Ke Geng, Ting Chen, Angeliki Karatza, Fiona Sherman, Kristen E. Labbe, Fan Yang, Alison Chafitz, Chengwei Peng, Chenchen Guo, Andre L. Moreira, Vamsidhar Velcheti, Sally C.M. Lau, Pengfei Sui, Haiquan Chen, J. Alan Diehl, Anil K. Rustgi, Adam J. Bass, John T. Poirier, Xiaoyang Zhang, Hongbin Ji, Hua Zhang & Kwok-Kin Wong. (2023) KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. Cancer Cell 41:1, pages 88-105.e8.
Crossref
Crossref
Yiping Lu, Wenfeng Zhang, Huayao Li, Cun Liu, Dandan Gao, Jing Zhuang, Ruijuan Liu, Jibiao Wu & Changgang Sun. (2022) The Mechanism of Quercetin in the Treatment of Lung Squamous Cell Carcinoma Based on a Protein-Protein Interaction Network. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-14.
Crossref
Crossref
Jianfeng Cai, Yiping Zheng, Lie Dong, Xiangbin Zhang & Yinghui Huang. (2022)
Circular
RNA
hsa_circ_0018189 drives non‐small cell lung cancer growth by sequestering
miR
‐656‐3p and enhancing
xCT
expression
. Journal of Clinical Laboratory Analysis 36:11.
Crossref
Crossref
Edgardo S. Santos & Estelamari Rodriguez. (2022) Treatment Considerations for Patients With Advanced Squamous Cell Carcinoma of the Lung. Clinical Lung Cancer 23:6, pages 457-466.
Crossref
Crossref
Qin Yang, Han Gong, Jing Liu, Mao Ye, Wen Zou & Hui Li. (2022) A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma. Scientific Reports 12:1.
Crossref
Crossref
Laura Boyero, Joel Martin-Padron, María Esther Fárez-Vidal, Maria Isabel Rodriguez, Álvaro Andrades, Paola Peinado, Alberto M. Arenas, Félix Ritoré-Salazar, Juan Carlos Alvarez-Perez, Marta Cuadros & Pedro P. Medina. (2022) PKP1 and MYC create a feedforward loop linking transcription and translation in squamous cell lung cancer. Cellular Oncology 45:2, pages 323-332.
Crossref
Crossref
涤非 曹. (2022) Study on Driver Genes of Non-Small Cell Lung Cancer. Hans Journal of Biomedicine 12:01, pages 9-17.
Crossref
Crossref
Mohammed A. S. Abourehab, Alaa M. Alqahtani, Bahaa G. M. Youssif & Ahmed M. Gouda. (2021) Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism. Molecules 26:21, pages 6677.
Crossref
Crossref
Cailian Wang, Xuyu Gu, Xiuxiu Zhang, Min Zhou & Yan Chen. (2021) Development and Validation of an E2F-Related Gene Signature to Predict Prognosis of Patients With Lung Squamous Cell Carcinoma. Frontiers in Oncology 11.
Crossref
Crossref
Zongxiu Yin, Yanna Yang, Tianfang Guo, Vishnu Priya Veeraraghavan & Xin Wang. (2021)
Potential chemotherapeutic effect of betalain against human
non‐small
cell lung cancer through
PI3K
/Akt/
mTOR
signaling pathway
. Environmental Toxicology 36:6, pages 1011-1020.
Crossref
Crossref
Jun Cui, Zheng Xiao & Lu-Lu Zhang. (2021) Clinical efficacy and safety of nazartinib for epidermal growth factor receptor mutated non-small cell lung cancer. Medicine 100:21, pages e25992.
Crossref
Crossref
Marta Serafini, Sarah Cargnin, Alberto Massarotti, Gian Cesare Tron, Tracey Pirali & Armando A. Genazzani. (2021) What’s in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications. Journal of Medicinal Chemistry 64:8, pages 4410-4429.
Crossref
Crossref